Evolent Health calls all $24.3 million 3.5% convertibles due 2024

By Wendy Van Sickle

Columbus, Ohio, Aug. 4 – Evolent Health, Inc. issued a notice that it will redeem its $24.3 million outstanding 3.5% convertible senior notes due 2024, according to an 8-K filing with the Securities and Exchange Commission.

The redemption will occur on Oct. 13 at a price of par plus interest.

Prior to the redemption date, holders are entitled to convert their notes to shares of the company’s class A common stock at a rate of 55.5198 shares per $1,000 principal amount. Fractional shares will be paid in cash.

The redemption will be funded with cash on hand.

Evolent Health is an Arlington, Va.-based company that partners with health care providers to implement value-based care.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.